AlzChem Group AG Capital Reinvestment Ratio

Latest as of December 2025: 4.54x

AlzChem Group AG capital reinvestment ratio. AlzChem Group AG (ACT) has a Capital Reinvestment Ratio of 4.54x as of December 2025, meaning it reinvests 5% of its operating cash flow (€21.52 Million) in capital expenditures (€97.79 Million). Check AlzChem Group AG investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

4.54x
Capex / Operating Cash Flow

Operating Cash Flow

€21.52 Million
EUR

Capital Expenditures

€97.79 Million
EUR

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of AlzChem Group AG (2012–2025)

Capital reinvestment ratio of AlzChem Group AG from 2012 to 2025. This chart tracks AlzChem Group AG's Capital Reinvestment Ratio across 11 annual periods. Also explore ACT year-over-year net asset growth to track the company's year-over-year net asset growth rate.

AlzChem Group AG Capital Reinvestment Ratio by Year (2012–2025)

AlzChem Group AG capital reinvestment ratio by year from 2012 to 2025. For the full cash flow conversion analysis, see AlzChem Group AG (ACT) cash flow conversion.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.71x €137.01 Million €97.79 Million ▲ +74.1%
2024 0.41x €105.15 Million €43.10 Million ▲ +44.9%
2023 0.28x €72.67 Million €20.56 Million ▼ -57.4%
2021 0.66x €43.02 Million €28.54 Million ▲ +12.1%
2020 0.59x €48.71 Million €28.83 Million ▼ -37.6%
2019 0.95x €43.63 Million €41.38 Million ▼ -18.1%
2018 1.16x €34.66 Million €40.13 Million ▲ +42.7%
2017 0.81x €30.66 Million €24.88 Million ▼ -100.0%
2014 264799.09x €140.11 €37.10 Million ▲ +23027514.6%
2013 1.15x €15.57 Million €17.91 Million ▲ +31.7%
2012 0.87x €20.71 Million €18.08 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow